MYO18B and hepatocellular carcinoma: In contrast, high MYO18B expression was correlated with poor prognosis in hepatocellular carcinoma and knockdown of MYO18B in HepG2 cells (human hepatocellular carcinoma cell line) decreased cell proliferation and invasiveness.